New study aims to bring autism therapy to more kids through public system

NCT ID NCT05114538

Ongoing Symptom relief Sponsor: Rush University Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 08, 2026 · Updated 2 times

Summary

This study tests whether training early intervention providers in Reciprocal Imitation Training can help children with autism improve imitation and communication skills. The program involves 440 children and their caregivers, with providers learning simple strategies during play. The goal is to make specialized autism therapy more accessible through the existing public early intervention system.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Reciprocal Imitation Training (a behavioral therapy)
What this could lead to: If successful, this could make evidence-based autism therapy more widely available through existing public early intervention systems, improving outcomes for many children.
What could go wrong: This is a behavioral intervention study, not a drug trial; results depend on provider training and caregiver engagement, and may not generalize to all settings or children.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autism spectrum disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AUTISM SPECTRUM DISORDER

Contacts and locations

Locations

Carol A Schubert

Seattle, Washington, 98195, United States
Michigan State University

East Lansing, Michigan, 48824, United States
Rush University Medical Center

Chicago, Illinois, 60612, United States
University of Massachusetts Boston

Boston, Massachusetts, 02125, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.